Peer-reviewedCC BY-NCCancer medicine
Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG‐rhG‐CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
- 1The Second People's Hospital of Yibin City
Related
- Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
- A Systematic Review and Meta-Analysis: Does Molecular Hydrogen Exert Radioprotective Effects Without Compromising the Antitumor Efficacy of Radiotherapy or Concurrent Chemoradiotherapy?
- Successful Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer in a Patient with Combined Pulmonary Fibrosis and Emphysema: A Case Report
- Safety of neoadjuvant radiotherapy or chemoradiotherapy combined with immunotherapy across solid tumors: Systematic review and meta-analysis protocol
- [Comment] Node-sparing modified short-course radiotherapy combined with CAPOX and tislelizumab versus conventional short-course preoperative chemoradiotherapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (mRCAT- Ⅲ): a multicenter, randomized, openlabel, phase 3 trial
BibTeX
@article{wang2026combined,
title = {{Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG‐rhG‐CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial}},
author = {ShanBing Wang and Jiapei Liu and Hui Zhong and Kaijian Lei and Chunxiu Wang and Xia Zhang and Ting Li and Yuming Jia},
journal = {Cancer medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13654572},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG‐rhG‐CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
AU - ShanBing Wang
AU - Jiapei Liu
AU - Hui Zhong
AU - Kaijian Lei
AU - Chunxiu Wang
AU - Xia Zhang
AU - Ting Li
AU - Yuming Jia
PY - 2026
DA - 2026/10/01
JO - Cancer medicine
UR - https://europepmc.org/article/PMC/PMC13654572
SN - 2045-7634
ER -